[1] 徐明喜,耿直.达格列净片联合二甲双胍维格列汀复方制剂治疗2型糖尿病患者的临床分析[J].基层医学论坛,2021,25(10):1412-1414.
[2] 孙志纯,洪真真,卓雅芬,等.利拉鲁肽联合甘精胰岛素与基础-餐时胰岛素强化治疗对新诊断2型糖尿病的疗效及安全性比较[J].中华糖尿病杂志,2021,13(1):60-65.
[3] 张乾慧,谭丽艳,杨阳,等.新诊断2型糖尿病患者血清Nesfatin-1水平变化与胰岛素抵抗的相关性研究[J].广东化工,2021,48(1):130-131.
[4] 魏雪芳,杨煜.达格列净联合胰岛素强化治疗对新诊断2型糖尿病患者的效果[J].中外医学研究,2021,19(1):134-136.
[5] 史萍. 维格列汀联合胰岛素强化治疗对新诊断2型糖尿病患者的疗效[J].河南医学研究,2020,29(35):6640-6642.
[6] 吴坚. 维格列汀联合二甲双胍对新诊断2型糖尿病患者血清Hcy、HOMA-IR水平的影响[J].航空航天医学杂志,2020,31(3):332-334.
[7] 冯毅. 维格列汀联合二甲双胍对新诊断2型糖尿病的疗效及对微炎性状态的影响[J].中国医学创新,2019,16(15):110-113. |
| [1] |
. [J]. journal1, 2022, 42(1): 109-110. |
| [2] |
. [J]. journal1, 2021, 41(6): 73-74. |
| [3] |
. [J]. journal1, 2021, 41(6): 55-56. |
| [4] |
Zheng Lianhua, He Xuwen, Liu Guolian, Niu Meng, Qiu Yanmin, Mai Juanjuan, Bai Yaru. Construction of Home Nursing Model of Elderly Type 2 Diabetic Patients Based on Family Doctor service[J]. journal1, 2021, 41(6): 40-42. |
| [5] |
. [J]. journal1, 2021, 41(3): 126-126. |
| [6] |
Li Yongbo. Investigation and Analysis of the Current Status of Dietary Nutrition Intervention For Type 2 Diabetes in Shanzhou District,Sanmenxia[J]. journal1, 2021, 41(2): 33-35. |
|
|
|
|
2022, Vol. 42 
